GridAI Technologies Stock (NASDAQ:GRDX)
Previous Close
$2.01
52W Range
$0.97 - $5.84
50D Avg
$3.53
200D Avg
$2.30
Market Cap
$9.48M
Avg Vol (3M)
$188.30K
Beta
1.15
Div Yield
-
GRDX Company Profile
GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.